Surface display of whole antibodies in eukaryotes

1. A method of producing yeast or filamentous fungi eukaryote host cells that produce an immunoglobulin having a heavy chain variable (VH) domain and a light chain variable (VL) domain and having an antigen binding site with binding specificity for an antigen of interest, the method comprising:

(a) providing a library of yeast or filamentous fungi eukaryote host cells displaying on their surface an immunoglobulin comprising a heavy chain having a VH domain fused to a heavy chain constant domain having an Fc domain and a light chain having a VL domain fused to a light chain constant domain, wherein the library is created by:

(i) providing yeast or filamentous fungi eukaryote host cells that express a capture moiety comprising a yeast or filamentous fungus cell surface anchoring protein fused to an immunoglobulin binding protein that binds to an immunoglobulin heavy chain Fc domain wherein expression of the capture moiety is controlled by a first regulatable promoter; and

(ii) transfecting the host cells with a library of nucleic acid molecules encoding a genetically diverse population of immunoglobulins, wherein the VH domains of the genetically diverse population of immunoglobulins are biased for one or more VH gene families and wherein expression of the heavy and light chains of the immunoglobulins are each controlled by a second regulatable promoter to produce a plurality of host cells, each expressing an immunoglobulin;

(b) inducing expression of the capture moiety in the host cells for a time sufficient to produce the capture moiety on the surface of the host cells;

(c) inhibiting expression of the capture moiety and inducing expression of the library of nucleic acid molecule sequences in the host cells, whereby each host cell displays an immunoglobulin bound to the capture moiety at the surface thereof to produce the host cells that produce the immunoglobulin having a VH domain and a VL domain and having the antigen binding site with binding specificity for the antigen of interest; and

(d) identifying host cells in the plurality of host cells that display immunoglobulins thereon that has a binding specificity for the antigen of interest by contacting the plurality of host cells with the antigen of interest and detecting the host cells that have the antigen of interest bound to the immunoglobulin displayed thereon to produce the host cells that produce the immunoglobulin having a VH domain and a VL domain and having the antigen binding site with binding specificity for the antigen of interest.

2. The method of claim 1 , wherein the nucleic acid molecules in step (a)(ii) each encode recombinant human immunoglobulin VH domain and a recombinant human immunoglobulin VL domain and wherein the recombinant human immunoglobulin VH domain and the recombinant human immunoglobulin VL domain each comprise framework regions and complementarity determining region (CDR) loops.

3. The method of claim 2 , wherein each human recombinant immunoglobulin VH and VL domain CDR loop is of random sequence.

4. The method of claim 2 , wherein human recombinant immunoglobulin VH and VL domain CDR loops are of known canonical structures and incorporate random sequence elements.

5. The method of claim 1 , wherein the immunoglobulin is selected from the group consisting of IgG1, IgG2, IgG3, and IgG4.

6. The method of claim 1 , wherein the immunoglobulin binding protein is selected from the group consisting of protein A, protein A ZZ domain, protein G, and protein L.

7. The method of claim 1 , wherein the cell surface anchoring protein is a GPI protein.

8. The method of claim 1 , wherein the VH domains are fused to a heavy chain constant domain selected from the group consisting of IgGI and IgG2 and the capture moiety binds to the Fc domain of the immunoglobulin.

9. The method of claim 1 , wherein the yeast or filamentous fungi eukaryote host cell is Saccharomyces cerevisiae or Pichia pastoris.

10. The method of claim 1 , wherein the host cells include a deletion of one or more of the genes encoding PMTs.

11. The method of claim 1 , wherein the host cells are cultivated in a medium that includes one or more Pmtp inhibitors.

12. The method of claim 1 , wherein the host cells include a deletion of one or more of the genes encoding PMTs and the host cells are cultivated in a medium that includes one or more Pmtp inhibitors.

13. The method of claim 1 , wherein the cell surface anchoring protein is selected from the group consisting of α-agglutinin, Cwp1p, Cwp2p, Gas1p, Yap3p, Flo1p, Crh2p, Pir1p, Pir4p, Sed1p, Tip1p, Hpwp1p, Als3p, and Rbt5p.

14. The method of claim 1 , wherein the cell surface anchoring protein is Sed1p.